Wall Street Experts
ver. ZuMIgo(08/25)
Revolution Medicines, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 1
EBIT TTM (mln): -634
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
0 |
20 |
50 |
43 |
29 |
35 |
12 |
0 |
| Przychód Δ r/r |
0.0% |
inf% |
148.2% |
-14.1% |
-31.6% |
20.4% |
-67.3% |
-100.0% |
| Marża brutto |
0.0% |
100.0% |
-83.4% |
-207.7% |
75.1% |
72.7% |
19.6% |
0.0% |
| EBIT (mln) |
-31 |
-40 |
-54 |
-111 |
-188 |
-258 |
-487 |
-690 |
| EBIT Δ r/r |
0.0% |
29.6% |
34.2% |
104.5% |
69.8% |
37.4% |
88.6% |
41.5% |
| EBIT (%) |
0.0% |
-200.0% |
-108.2% |
-257.5% |
-639.7% |
-730.0% |
-4207.1% |
0.0% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
-10 |
0 |
0 |
| EBITDA (mln) |
-30 |
-40 |
-49 |
-108 |
-187 |
-249 |
-478 |
-690 |
| EBITDA(%) |
0.0% |
-197.9% |
-97.1% |
-252.3% |
-636.5% |
-704.1% |
-4126.7% |
0.0% |
| Podatek (mln) |
0 |
-1 |
-4 |
-0 |
-7 |
-0 |
-4 |
1 |
| Zysk Netto (mln) |
-31 |
-42 |
-48 |
-108 |
-180 |
-249 |
-436 |
-600 |
| Zysk netto Δ r/r |
0.0% |
34.3% |
14.1% |
126.9% |
66.2% |
38.3% |
75.5% |
37.5% |
| Zysk netto (%) |
0.0% |
-207.2% |
-95.2% |
-251.6% |
-611.7% |
-703.0% |
-3768.3% |
0.0% |
| EPS |
-0.85 |
-1.15 |
-0.81 |
-1.62 |
-2.47 |
-3.08 |
-3.86 |
-3.58 |
| EPS (rozwodnione) |
-0.85 |
-1.15 |
-0.81 |
-1.62 |
-2.47 |
-3.08 |
-3.86 |
-3.58 |
| Ilośc akcji (mln) |
36 |
36 |
59 |
67 |
73 |
81 |
113 |
168 |
| Ważona ilośc akcji (mln) |
36 |
36 |
59 |
67 |
73 |
81 |
113 |
168 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |